Chédiak-Higashi gene in humans I. Impairment of natural-killer function

Natural-killer (NK)-cell function was profoundly depressed in donors homozygous for the Chediak-Steinbrinck-Higashi syndrome (C-HS) gene when compared with age- and sex-matched normals. This apparent defect was not simply a result of a delayed response because little cytolysis was evident in kinetic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of experimental medicine 1980-05, Vol.151 (5), p.1039-1048
Hauptverfasser: Haliotis, T, Roder, J, Klein, M, Ortaldo, J, Fauci, A S, Herberman, R B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1048
container_issue 5
container_start_page 1039
container_title The Journal of experimental medicine
container_volume 151
creator Haliotis, T
Roder, J
Klein, M
Ortaldo, J
Fauci, A S
Herberman, R B
description Natural-killer (NK)-cell function was profoundly depressed in donors homozygous for the Chediak-Steinbrinck-Higashi syndrome (C-HS) gene when compared with age- and sex-matched normals. This apparent defect was not simply a result of a delayed response because little cytolysis was evident in kinetics experiments even after 24 h of incubation. NK cells from C-HS donors failed to lyse adherent (MDA, CEM, and Alab) or nonadherent (K562 and Molt-4) tumor cell lines or nontransformed human fetal fibroblasts. Therefore, the apparent C-HS defect was not a result of a shift in target selectivities. In addition, the depressed reactivity did not appear to be a result of suppressor cells or factors because: (a) enriched NK populations (nonadherent lymphocytes bearing receptors for the Fc portion of IgG) from C-HS donors were low in NK-cell function, (b) C-HS mononuclear cells did not inhibit the cytotoxicity of normal cells in coculture experiments, and (c) cells from the C-HS donors remained poorly reactive even after culture for up to 7 d. The nature of the defective NK activity in C-HS patients is not clear but may lie within the lytic mechanism rather than at the level of the recognition structure or population size because the frequency of target-binding cells was normal. In vitro NK activity could be partially restored by interferon treatment. Combined with the results presented in the following paper (4), these observations suggest that the C-HS gene causes a selective immunodeficiency disorder, mainly involving NK cells. This finding, in conjunction with the high incidence of spontaneous possibly malignant, lymphoproliferative disorders in these patients, may have important implications regarding the theory of immune surveillance mediated by NK cells.
doi_str_mv 10.1084/jem.151.5.1039
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2185857</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75105883</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3669-602951dd4c4f2c6485cbf1063f3e9d4ffcb507ffcf716d600343ebbd795a9b573</originalsourceid><addsrcrecordid>eNpVkM1OwzAQhC0EKqVw5YbkE7cEO_5JckFCFdBKlbjA2XIcu3GbOMVukHgknoMXw6VVBafRamdnRx8A1xilGBX0bqW7FDOcsjiS8gSMMaMoKRkpTsEYoSxLMEL5ObgIYYUQppTxERjx6Mo5G4PZtPn-qq1cJzO7lKGxcKmdhtbBZuikC3Cewnm3kdZ32m1hb6CT28HLNlnbttUemsGpre3dJTgzsg366qAT8Pb0-DqdJYuX5_n0YZEownmZcJSVDNc1VdRkitOCqcpgxIkhuqypMapiKI9icsxrjhChRFdVnZdMlhXLyQTc73M3Q9XpWsVWsY3YeNtJ_yl6acX_jbONWPYfIsMFK34Dbg8Bvn8fdNiKzgal21Y63Q9B5AwjVhQkGtO9Ufk-BK_N8QlGYsdeRPYishdM7NjHg5u_1Y72A2zyA6q0gXw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75105883</pqid></control><display><type>article</type><title>Chédiak-Higashi gene in humans I. Impairment of natural-killer function</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Haliotis, T ; Roder, J ; Klein, M ; Ortaldo, J ; Fauci, A S ; Herberman, R B</creator><creatorcontrib>Haliotis, T ; Roder, J ; Klein, M ; Ortaldo, J ; Fauci, A S ; Herberman, R B</creatorcontrib><description>Natural-killer (NK)-cell function was profoundly depressed in donors homozygous for the Chediak-Steinbrinck-Higashi syndrome (C-HS) gene when compared with age- and sex-matched normals. This apparent defect was not simply a result of a delayed response because little cytolysis was evident in kinetics experiments even after 24 h of incubation. NK cells from C-HS donors failed to lyse adherent (MDA, CEM, and Alab) or nonadherent (K562 and Molt-4) tumor cell lines or nontransformed human fetal fibroblasts. Therefore, the apparent C-HS defect was not a result of a shift in target selectivities. In addition, the depressed reactivity did not appear to be a result of suppressor cells or factors because: (a) enriched NK populations (nonadherent lymphocytes bearing receptors for the Fc portion of IgG) from C-HS donors were low in NK-cell function, (b) C-HS mononuclear cells did not inhibit the cytotoxicity of normal cells in coculture experiments, and (c) cells from the C-HS donors remained poorly reactive even after culture for up to 7 d. The nature of the defective NK activity in C-HS patients is not clear but may lie within the lytic mechanism rather than at the level of the recognition structure or population size because the frequency of target-binding cells was normal. In vitro NK activity could be partially restored by interferon treatment. Combined with the results presented in the following paper (4), these observations suggest that the C-HS gene causes a selective immunodeficiency disorder, mainly involving NK cells. This finding, in conjunction with the high incidence of spontaneous possibly malignant, lymphoproliferative disorders in these patients, may have important implications regarding the theory of immune surveillance mediated by NK cells.</description><identifier>ISSN: 0022-1007</identifier><identifier>EISSN: 1540-9538</identifier><identifier>DOI: 10.1084/jem.151.5.1039</identifier><identifier>PMID: 6154765</identifier><language>eng</language><publisher>United States: The Rockefeller University Press</publisher><subject>Adult ; Cells, Cultured ; Chediak-Higashi Syndrome - immunology ; Humans ; Immunity, Cellular ; Immunity, Innate - drug effects ; Interferons - pharmacology ; Killer Cells, Natural - immunology ; Lymphocytes - immunology ; Male ; T-Lymphocytes, Regulatory - immunology</subject><ispartof>The Journal of experimental medicine, 1980-05, Vol.151 (5), p.1039-1048</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3669-602951dd4c4f2c6485cbf1063f3e9d4ffcb507ffcf716d600343ebbd795a9b573</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6154765$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Haliotis, T</creatorcontrib><creatorcontrib>Roder, J</creatorcontrib><creatorcontrib>Klein, M</creatorcontrib><creatorcontrib>Ortaldo, J</creatorcontrib><creatorcontrib>Fauci, A S</creatorcontrib><creatorcontrib>Herberman, R B</creatorcontrib><title>Chédiak-Higashi gene in humans I. Impairment of natural-killer function</title><title>The Journal of experimental medicine</title><addtitle>J Exp Med</addtitle><description>Natural-killer (NK)-cell function was profoundly depressed in donors homozygous for the Chediak-Steinbrinck-Higashi syndrome (C-HS) gene when compared with age- and sex-matched normals. This apparent defect was not simply a result of a delayed response because little cytolysis was evident in kinetics experiments even after 24 h of incubation. NK cells from C-HS donors failed to lyse adherent (MDA, CEM, and Alab) or nonadherent (K562 and Molt-4) tumor cell lines or nontransformed human fetal fibroblasts. Therefore, the apparent C-HS defect was not a result of a shift in target selectivities. In addition, the depressed reactivity did not appear to be a result of suppressor cells or factors because: (a) enriched NK populations (nonadherent lymphocytes bearing receptors for the Fc portion of IgG) from C-HS donors were low in NK-cell function, (b) C-HS mononuclear cells did not inhibit the cytotoxicity of normal cells in coculture experiments, and (c) cells from the C-HS donors remained poorly reactive even after culture for up to 7 d. The nature of the defective NK activity in C-HS patients is not clear but may lie within the lytic mechanism rather than at the level of the recognition structure or population size because the frequency of target-binding cells was normal. In vitro NK activity could be partially restored by interferon treatment. Combined with the results presented in the following paper (4), these observations suggest that the C-HS gene causes a selective immunodeficiency disorder, mainly involving NK cells. This finding, in conjunction with the high incidence of spontaneous possibly malignant, lymphoproliferative disorders in these patients, may have important implications regarding the theory of immune surveillance mediated by NK cells.</description><subject>Adult</subject><subject>Cells, Cultured</subject><subject>Chediak-Higashi Syndrome - immunology</subject><subject>Humans</subject><subject>Immunity, Cellular</subject><subject>Immunity, Innate - drug effects</subject><subject>Interferons - pharmacology</subject><subject>Killer Cells, Natural - immunology</subject><subject>Lymphocytes - immunology</subject><subject>Male</subject><subject>T-Lymphocytes, Regulatory - immunology</subject><issn>0022-1007</issn><issn>1540-9538</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1980</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkM1OwzAQhC0EKqVw5YbkE7cEO_5JckFCFdBKlbjA2XIcu3GbOMVukHgknoMXw6VVBafRamdnRx8A1xilGBX0bqW7FDOcsjiS8gSMMaMoKRkpTsEYoSxLMEL5ObgIYYUQppTxERjx6Mo5G4PZtPn-qq1cJzO7lKGxcKmdhtbBZuikC3Cewnm3kdZ32m1hb6CT28HLNlnbttUemsGpre3dJTgzsg366qAT8Pb0-DqdJYuX5_n0YZEownmZcJSVDNc1VdRkitOCqcpgxIkhuqypMapiKI9icsxrjhChRFdVnZdMlhXLyQTc73M3Q9XpWsVWsY3YeNtJ_yl6acX_jbONWPYfIsMFK34Dbg8Bvn8fdNiKzgal21Y63Q9B5AwjVhQkGtO9Ufk-BK_N8QlGYsdeRPYishdM7NjHg5u_1Y72A2zyA6q0gXw</recordid><startdate>19800501</startdate><enddate>19800501</enddate><creator>Haliotis, T</creator><creator>Roder, J</creator><creator>Klein, M</creator><creator>Ortaldo, J</creator><creator>Fauci, A S</creator><creator>Herberman, R B</creator><general>The Rockefeller University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19800501</creationdate><title>Chédiak-Higashi gene in humans I. Impairment of natural-killer function</title><author>Haliotis, T ; Roder, J ; Klein, M ; Ortaldo, J ; Fauci, A S ; Herberman, R B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3669-602951dd4c4f2c6485cbf1063f3e9d4ffcb507ffcf716d600343ebbd795a9b573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1980</creationdate><topic>Adult</topic><topic>Cells, Cultured</topic><topic>Chediak-Higashi Syndrome - immunology</topic><topic>Humans</topic><topic>Immunity, Cellular</topic><topic>Immunity, Innate - drug effects</topic><topic>Interferons - pharmacology</topic><topic>Killer Cells, Natural - immunology</topic><topic>Lymphocytes - immunology</topic><topic>Male</topic><topic>T-Lymphocytes, Regulatory - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haliotis, T</creatorcontrib><creatorcontrib>Roder, J</creatorcontrib><creatorcontrib>Klein, M</creatorcontrib><creatorcontrib>Ortaldo, J</creatorcontrib><creatorcontrib>Fauci, A S</creatorcontrib><creatorcontrib>Herberman, R B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of experimental medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haliotis, T</au><au>Roder, J</au><au>Klein, M</au><au>Ortaldo, J</au><au>Fauci, A S</au><au>Herberman, R B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chédiak-Higashi gene in humans I. Impairment of natural-killer function</atitle><jtitle>The Journal of experimental medicine</jtitle><addtitle>J Exp Med</addtitle><date>1980-05-01</date><risdate>1980</risdate><volume>151</volume><issue>5</issue><spage>1039</spage><epage>1048</epage><pages>1039-1048</pages><issn>0022-1007</issn><eissn>1540-9538</eissn><abstract>Natural-killer (NK)-cell function was profoundly depressed in donors homozygous for the Chediak-Steinbrinck-Higashi syndrome (C-HS) gene when compared with age- and sex-matched normals. This apparent defect was not simply a result of a delayed response because little cytolysis was evident in kinetics experiments even after 24 h of incubation. NK cells from C-HS donors failed to lyse adherent (MDA, CEM, and Alab) or nonadherent (K562 and Molt-4) tumor cell lines or nontransformed human fetal fibroblasts. Therefore, the apparent C-HS defect was not a result of a shift in target selectivities. In addition, the depressed reactivity did not appear to be a result of suppressor cells or factors because: (a) enriched NK populations (nonadherent lymphocytes bearing receptors for the Fc portion of IgG) from C-HS donors were low in NK-cell function, (b) C-HS mononuclear cells did not inhibit the cytotoxicity of normal cells in coculture experiments, and (c) cells from the C-HS donors remained poorly reactive even after culture for up to 7 d. The nature of the defective NK activity in C-HS patients is not clear but may lie within the lytic mechanism rather than at the level of the recognition structure or population size because the frequency of target-binding cells was normal. In vitro NK activity could be partially restored by interferon treatment. Combined with the results presented in the following paper (4), these observations suggest that the C-HS gene causes a selective immunodeficiency disorder, mainly involving NK cells. This finding, in conjunction with the high incidence of spontaneous possibly malignant, lymphoproliferative disorders in these patients, may have important implications regarding the theory of immune surveillance mediated by NK cells.</abstract><cop>United States</cop><pub>The Rockefeller University Press</pub><pmid>6154765</pmid><doi>10.1084/jem.151.5.1039</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1007
ispartof The Journal of experimental medicine, 1980-05, Vol.151 (5), p.1039-1048
issn 0022-1007
1540-9538
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2185857
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adult
Cells, Cultured
Chediak-Higashi Syndrome - immunology
Humans
Immunity, Cellular
Immunity, Innate - drug effects
Interferons - pharmacology
Killer Cells, Natural - immunology
Lymphocytes - immunology
Male
T-Lymphocytes, Regulatory - immunology
title Chédiak-Higashi gene in humans I. Impairment of natural-killer function
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T19%3A35%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ch%C3%A9diak-Higashi%20gene%20in%20humans%20I.%20Impairment%20of%20natural-killer%20function&rft.jtitle=The%20Journal%20of%20experimental%20medicine&rft.au=Haliotis,%20T&rft.date=1980-05-01&rft.volume=151&rft.issue=5&rft.spage=1039&rft.epage=1048&rft.pages=1039-1048&rft.issn=0022-1007&rft.eissn=1540-9538&rft_id=info:doi/10.1084/jem.151.5.1039&rft_dat=%3Cproquest_pubme%3E75105883%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75105883&rft_id=info:pmid/6154765&rfr_iscdi=true